FDA Inspection
Haupt Pharma Wuelfing GmbHHaupt Pharma Wuelfing GmbH – FDA Inspection, Mar 28, 2014
Record Details
This FDA Inspection record concerns Haupt Pharma Wuelfing GmbH, with an inspection on March 28, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Haupt Pharma Wuelfing GmbH
- Inspection Date
- March 28, 2014
- Product Type
- Drugs
View Company Profile
ID · e11928da-72ea-4175-a402-6e454fbd604d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 877801
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Haupt Pharma Wuelfing GmbH
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 7, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2018 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
| March 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 16, 2015 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Haupt Pharma Wuelfing GmbH
- FDA Inspection 1275631 - 2023-06-06
- FDA Inspection 1088285 - 2018-12-07
- FDA Inspection 1061723 - 2018-08-10
- FDA Inspection 1009773 - 2017-03-17
- FDA Inspection 931397 - 2015-06-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.